In a 24-hour period, $1.622 billion worth of crypto positions were liquidated, with Bitcoin longs accounting for $901 million, or about 56% of the total. Long positions made up roughly 90% of all liquidations, indicating a sharp sell-off of bullish bets across the market. Ether liquidations followed at $248 million, with BTC and ETH combined representing 71% of all forced closures. This broad unwind highlights a significant shift away from bullish leverage in crypto markets, particularly in Bitcoin and Ether.
Bitcoin liquidations reached $901 million, making up about 56% of a total $1.622 billion in crypto liquidations within 24 hours. For readers following the broader crypto market, here is Pluang's market snapshot as of Nov 13, 2026 12:51 WIB: out of 50 major cryptocurrencies, 8 rose and 41 fell today. Notable movers include CAKE at Rp31.203 with a 4.13% decline and 85% sell order activity, DOGE at Rp1.166 down 3.95% with a balanced buy/sell split, and FIL at Rp13.040 down 3.91% with 95% sell orders.
The 9th Shandong-South Korea Economic and Trade Cooperation Conference and Yantai South Korea Week began on November 6 in Yantai, Shandong Province, highlighting strong economic ties between Shandong and South Korea. Over 150 enterprises participated...
Bitcoin plunged to a nearly three-month low of $67,500 on November 12, extending its November losses beyond 11%, driven by heavy sell-offs and market uncertainty following the ouster of Nvidia's CEO. Crypto liquidations surged to $1.62 billion, with ...
South Korean crypto exchange Upbit has temporarily suspended deposits and withdrawals of Osmosis (OSMO) following a network-wide stall where the Osmosis blockchain stopped producing new blocks at height 74,955,152 on November 12, 2026. Despite this, ...
First Phosphate Corp. is reaffirmed as a speculative Buy due to its strong balance sheet and significant government and export credit support, including a $212.5M SERV letter. The company’s Bégin Lamarche project is supported by these financial stren...
4D Molecular Therapeutics reported a wider adjusted loss of $1.08 per share for Q3 2026, missing analyst expectations. However, the company's revenue reached $4.15 million, surpassing both estimates and last year's figures, continuing a trend of stro...
